Cloned (Comment) | Organism |
---|---|
DNA and amino acid sequence determination and analysis, sequence comparisons, RT-PCR and real-time PCR expression analysis | Sus scrofa |
Protein Variants | Comment | Organism |
---|---|---|
L498I | the naturally occuring mutation T1564C creates a c-Rel binding site | Sus scrofa |
M430T | naturally occuring mutation T1392C | Sus scrofa |
additional information | identification of five single nucleotide polymorphisms, three of them are synonymous mutations and the other two are missense mutations, the naturally occuring mutation T1541C causes a deletion of a CdxA element and a C/EBP binding site and created a c-Ets-binding site, and naturally occuring mutation G973T in exon 9, which is a synonymous mutation | Sus scrofa |
Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
---|---|---|---|
97150 | - |
x * 97150, sequence calculation | Sus scrofa |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
(S)-3-hydroxy-3-methylglutaryl-CoA + 2 NADPH + 2 H+ | Sus scrofa | - |
(R)-mevalonate + CoA + 2 NADP+ | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Sus scrofa | Q1W675 | - |
- |
Posttranslational Modification | Comment | Organism |
---|---|---|
glycoprotein | identification of five N-glycosylation sites | Sus scrofa |
lipoprotein | identification of nineteen N-myristoylation sites and three characteristic sites | Sus scrofa |
phosphoprotein | identification of a cAMP-and cGMP-dependent protein kinase phosphorylation site, thirteen Protein kinase C phosphorylation sites, and eleven Casein kinase II phosphorylation sites | Sus scrofa |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
adipose tissue | subcutaneous, high expression level | Sus scrofa | - |
bladder | high expression level | Sus scrofa | - |
cerebrum | low expression level | Sus scrofa | - |
heart | high expression level | Sus scrofa | - |
kidney | high expression level | Sus scrofa | - |
large intestine | medium expression level | Sus scrofa | - |
liver | high expression level | Sus scrofa | - |
lung | medium expression level | Sus scrofa | - |
ovary | low expression level | Sus scrofa | - |
skeletal muscle | longissimus, low expression level | Sus scrofa | - |
small intestine | low expression level | Sus scrofa | - |
spinal cord | low expression level | Sus scrofa | - |
spleen | low expression level | Sus scrofa | - |
stomach | low expression level | Sus scrofa | - |
uterus | medium expression level | Sus scrofa | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
(S)-3-hydroxy-3-methylglutaryl-CoA + 2 NADPH + 2 H+ | - |
Sus scrofa | (R)-mevalonate + CoA + 2 NADP+ | - |
? |
Subunits | Comment | Organism |
---|---|---|
? | x * 97150, sequence calculation | Sus scrofa |
Synonyms | Comment | Organism |
---|---|---|
3-hydroxy-3-methylglutaryl-coenzyme A reductase | - |
Sus scrofa |
HMGR | - |
Sus scrofa |
Cofactor | Comment | Organism | Structure |
---|---|---|---|
NADPH | - |
Sus scrofa |
Organism | Comment | pI Value Maximum | pI Value |
---|---|---|---|
Sus scrofa | sequence calculation | - |
6.14 |
General Information | Comment | Organism |
---|---|---|
additional information | structure-function analysis, overview. Identification of three characteristic sites of hydroxymethylglutaryl-CoA reductase | Sus scrofa |
physiological function | rate-limiting enzyme for cholesterol synthesis, regulated via a negative feedback mechanism through sterols and non-sterol metabolites derived from mevalonate | Sus scrofa |